MARIO GARDNER: Open Payments
NPI 1679117451 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 21 payments from 13 companies in 2025. Trend: 2023 $860 · 2024 $756 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $104 |
| ViiV Healthcare Company | 4 | $98 |
| Insmed, Inc. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Valinor Pharma, LLC | 1 | $20 |
| Philips North America LLC | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
Products named: Intracept, DOVATO, Arikayce, ZERBAXA, APRETUDE, XERAVA, VOWST, Fixate.
Industry payments across FL — which companies pay providers there.
